Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 233,351 $ 136,858
Accounts receivable, net 19,349 13,539
Inventory 1,404 857
Other receivables - related party 744 865
Prepaid expenses and other current assets 6,723 4,133
Total current assets 261,571 156,252
Property and equipment, net 11,923 12,433
Operating lease right-of-use asset, net 20,487 21,480
Restricted cash 1,645 16,574
Long-term investment, at fair value 17,566 11,148
Intangible asset, net 14,629 7,377
Other assets 1,013 1,158
Total assets 328,834 226,422
Current liabilities    
Accounts payable and accrued expenses 40,674 35,451
Interest payable 0 1,042
Interest payable - related party 0 92
Notes payable, short-term 0 7,220
Income taxes payable 136 0
Operating lease liabilities - short-term 1,849 1,784
Derivative warrant liability 0 27
Other current liabilities 5,300 0
Total current liabilities 47,959 45,616
Notes payable, long-term (net of debt discount of $8,323 and $5,086 at December 31, 2020 and December 31, 2019, respectively) 51,677 77,436
Operating lease liabilities, long-term 22,891 23,712
Partner company note payable, long-term 7,359 4,990
Other long-term liabilities 1,949 2,136
Total liabilities 131,835 153,890
Commitments and contingencies
Stockholders' equity    
Cumulative redeemable perpetual preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 3,427,138 and 1,341,167 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively; liquidation value of $25.00 per share 3 1
Common stock, $.001 par value, 150,000,000 and 100,000,000 shares authorized, 94,877,492 and 74,027,425 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively 95 74
Common stock issuable, 0 and 251,337 shares as of December 31, 2020 and December 31, 2019, respectively 0 500
Additional paid-in-capital 583,000 461,874
Accumulated deficit (482,760) (436,234)
Total stockholders' equity attributed to the Company 100,338 26,215
Non-controlling interests 96,661 46,317
Total stockholders' equity 196,999 72,532
Total liabilities and stockholders' equity $ 328,834 $ 226,422